Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Gyo Sagara
|
| gptkbp:collaboratedWith |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:founded |
1717
|
| gptkbp:headquarters_location |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ono Pharmaceutical
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Opdivo
gptkb:Stivarga gptkb:Emend |
| gptkbp:numberOfEmployees |
3,500+
|
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4528
|
| gptkbp:website |
https://www.ono.co.jp/eng/
|
| gptkbp:bfsParent |
gptkb:Fast_IDentity_Online
gptkb:Nivolumab |
| gptkbp:bfsLayer |
7
|